Skip to main content
    • Aa
    • Aa

Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated

  • S. X. Tang (a1), J. J. Yi (a2), M. E. Calkins (a1), D. A. Whinna (a1), C. G. Kohler (a1), M. C. Souders (a3), D. M. McDonald-McGinn (a3), E. H. Zackai (a3) (a4), B. S. Emanuel (a3) (a4), R. C. Gur (a1) and R. E. Gur (a1)...

Chromosome 22q11.2 deletion syndrome (22q11DS) is a common genetic disorder with high rates of psychosis and other psychopathologies, but few studies discuss treatment. Our aim was to characterize the prevalence and treatment of major psychiatric illnesses in a well-characterized sample of individuals with 22q11DS.


This was a cross-sectional study of 112 individuals aged 8 to 45 years with a confirmed diagnosis of 22q11DS. Each participant was administered a modified Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS) and the Structured Interview for Prodromal Syndromes (SIPS). Phenotypes assessed were threshold and subthreshold psychosis, depression, mania, generalized and separation anxiety, obsessions/compulsions, inattention/hyperactivity and substance use. Histories of mental health care and current psychotropic treatment were obtained.


Psychopathology was common, with 79% of individuals meeting diagnostic criteria for a disorder at the time of assessment. Diagnoses of psychosis were made in 11% of cases, attenuated positive symptom syndrome (APS) in 21%, and 47% experienced significant subthreshold symptoms. Peak occurrence of psychosis risk was during adolescence (62% of those aged 12–17 years). Criteria for a mood disorder were met by 14%, for anxiety disorder 34% and for attention deficit hyperactivity disorder (ADHD) 31%. Mental health care had been received by 63% of individuals in their lifetime, but only 40% continued therapy and 39% used psychotropics. Antipsychotics were used by 42% of participants with psychosis and none of the participants with APS. Half of those at risk for psychosis were receiving no mental health care.


Psychopathology is common in 22q11DS but is not adequately treated or clinically followed. Particular attention should be paid to subthreshold psychotic symptoms, especially in adolescents.

Corresponding author
* Address for correspondence: R. E. Gur, M.D., Ph.D., Neuropsychiatry Section, University of Pennsylvania, Perelman School of Medicine, 10th Floor Gates Building, Philadelphia, PA 19104, USA. (Email:
Hide All
AntshelKM, FremontW, RoizenNJ, ShprintzenR, HigginsAM, DhamoonA, KatesWR (2006). ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 45, 596603.
AntshelKM, ShprintzenR, FremontW, HigginsAM, FaraoneSV, KatesWR (2010). Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 49, 333344.
BassettAS, ChowEW (2008). Schizophrenia and 22q11.2 deletion syndrome. Current Psychiatry Reports 10, 148157.
BassettAS, ChowEW, AbdelMalikP, GheorghiuM, HustedJ, WeksbergR (2003). The schizophrenia phenotype in 22q11 deletion syndrome. American Journal of Psychiatry 160, 15801586.
BassettAS, McDonald-McGinnDM, DevriendtK, DigilioMC, GoldenbergP, HabelA, MarinoB, OskarsdottirS, PhilipN, SullivanK, SwillenA, VorstmanJ; International 22q11.2 Deletion Syndrome Consortium (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. Journal of Pediatrics 159, 332–9.e1.
BottoLD, MayK, FernhoffPM, CorreaA, ColemanK, RasmussenSA, MerrittRK, O'LearyLA, WongL-Y, ElixsonEM (2003). A population-based study of the 22q11. 2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112, 101107.
DreessenL, ArntzA (1998). Short-interval test-retest interrater reliability of the Structured Clinical Interview for DSM-III-R personality disorders (SCID-II) in outpatients. Journal of Personality Disorders 12, 138148.
FabbroA, RizziE, SchneiderM, DebbaneM, EliezS (2012). Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS). European Child and Adolescent Psychiatry 21, 379385.
FirstMB, GibbonM (2004). The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). In Comprehensive Handbook of Psychological Assessment. Vol. 2, Personality Assessment (ed. Hilsenroth M. J. and Segal D. L.), pp. 134143. John Wiley & Sons, Inc.: Hoboken, NJ.
GoldenbergPC, CalkinsME, RichardJ, McDonald-McGinnD, ZackaiE, MitraN, EmanuelB, DevotoM, Borgmann-WinterK, KohlerC, ConroyCG, GurRC, GurRE (2012). Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 159B, 8793.
GothelfD, FeinsteinC, ThompsonT, GuE, PennimanL, Van StoneE, KwonH, EliezS, ReissAL (2007). Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. American Journal of Psychiatry 164, 663669.
GreenT, GothelfD, GlaserB, DebbaneM, FrischA, KotlerM, WeizmanA, EliezS (2009). Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 48, 10601068.
GurRE, KohlerC, TuretskyBI, SiegelSJ, KanesSJ, BilkerWB, BrennanAR, GurRC (2004). A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biological Psychiatry 55, 512517.
HafnerH, an der HeidenW, BehrensS, GattazWF, HambrechtM, LofflerW, MaurerK, Munk-JorgensenP, NowotnyB, Riecher-RosslerA, SteinA (1998). Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophrenia Bulletin 24, 99113.
JawadAF, McDonald-McGinnDM, ZackaiE, SullivanKE (2001). Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Journal of Pediatrics 139, 715723.
JolinEM, WellerRA, JessaniNR, ZackaiEH, McDonald-McGinnDM, WellerEB (2009). Affective disorders and other psychiatric diagnoses in children and adolescents with 22q11.2 deletion syndrome. Journal of Affective Disorders 119, 177180.
JolinEM, WellerRA, WellerEB (2012). Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. Journal of Affective Disorders 136, 222228.
KaufmanJ, BirmaherB, BrentD, RaoU, FlynnC, MoreciP, WilliamsonD, RyanN (1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children – Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 36, 980988.
McDonald-McGinnDM, Minugh-PurvisN, KirschnerRE, JawadA, TonnesenMK, CatanzaroJR, GoldmuntzE, DriscollD, LarossaD, EmanuelBS, ZackaiEH (2005). The 22q11.2 deletion in African-American patients: an underdiagnosed population? American Journal of Medical Genetics . Part A 134, 242246.
McDonald-McGinnDM, TonnesenMK, Laufer-CahanaA, FinucaneB, DriscollDA, EmanuelBS, ZackaiEH (2001). Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genetics in Medicine 3, 2329.
MerikangasKR, HeJ-P, RapoportJ, VitielloB, OlfsonM (2013). Medication use in US youth with mental disorders. JAMA Pediatrics 167, 141148.
MerikangasKR, HeMJ-P, BursteinM, SwansonMSA, AvenevoliS, CuiML, BenjetC, GeorgiadesK, SwendsenJ (2010). Lifetime prevalence of mental disorders in US adolescents: results from the National Comorbidity Study – Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 49, 980989.
MichaelovskyE, FrischA, CarmelM, PatyaM, ZarchiO, GreenT, Basel-VanagaiteL, WeizmanA, GothelfD (2012). Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Medical Genetics 13, 122.
MillerTJ, McGlashanTH, RosenJL, CadenheadK, CannonT, VenturaJ, McFarlaneW, PerkinsDO, PearlsonGD, WoodsSW (2003). Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703715.
MurphyKC, JonesLA, OwenMJ (1999). High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry 56, 940945.
NiklassonL, RasmussenP, OskarsdóttirS, GillbergC (2009). Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Research in Developmental Disabilities 30, 763773.
SchreinerMJ, LazaroMT, JalbrzikowskiM, BeardenCE (2013). Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome. Neuropharmacology 68, 157173.
ShapiroDI, CubellsJF, OusleyOY, RockersK, WalkerEF (2011). Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder. Schizophrenia Research 129, 2028.
StoddardJ, NiendamT, HendrenR, CarterC, SimonTJ (2010). Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophrenia Research 118, 118121.
VeerapandiyanA, Abdul-RahmanOA, AdamMP, LyonsMJ, ManningM, ColemanK, KobrynskiL, TanejaD, SchochK, ZimmermanHH, ShashiV (2011). Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge. American Journal of Medical Genetics. Part A 155A, 21862195.
VorstmanJA, MorcusME, DuijffSN, KlaassenPW, Heineman-de BoerJA, BeemerFA, SwaabH, KahnRS, van EngelandH (2006). The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 45, 11041113.
WapnerRJ, MartinCL, LevyB, BallifBC, EngCM, ZacharyJM, SavageM, PlattLD, SaltzmanD, GrobmanWA, KlugmanS, SchollT, SimpsonJL, McCallK, AggarwalVS, BunkeB, NahumO, PatelA, LambAN, ThomEA, BeaudetAL, LedbetterDH, ShafferLG, JacksonL (2012). Chromosomal microarray versus karyotyping for prenatal diagnosis. New England Journal of Medicine 367, 21752184.
WilkinsonGS, RobertsonGJ (2006). Wide Range Achievement Test, Fourth Edition (WRAT4). Psychological Assessment Resources: Lutz, FL.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 5
Total number of PDF views: 44 *
Loading metrics...

Abstract views

Total abstract views: 329 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.